Ligand Pharmaceuticals | LGND - Market Capitalization

Stock Price
191.35
Daily Change
2.35 1.24%
Monthly
-3.47%
Yearly
66.38%
Q1 Forecast
178.28

Ligand Pharmaceuticals reported $3.35B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 204M 164M Jun/2025
Amgen USD 201.45B 25.2B Feb/2026
Anika Therapeutics USD 379M 166M Jun/2025
Arrowhead Research USD 8.04B 973M Feb/2026
Baxter International USD 9.54B 279M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Enanta Pharmaceuticals USD 198M 37M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Heron Therapeutics USD 145M 6M Sep/2023
Insmed USD 23.91B 13.21B Feb/2026
Intrexon USD 363M 69M Sep/2023
Ionis Pharmaceuticals USD 12.16B 652M Feb/2026
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Rigel Pharmaceuticals USD 188M 36M Sep/2023
Veracyte USD 2.8B 98M Feb/2026